NDC 61314-318 – Zarxio

Filgrastim 300 ug/.5mL · Injection, Solution · Intravenous, Subcutaneous

Human Prescription Drug

Product NDC61314-318

Product details

Brand name
Zarxio
Generic name
filgrastim-sndz
Labeler
Sandoz Inc.
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Marketing category
BLA · BLA125553
Marketed since
March 6, 2015
Listing expires
December 31, 2027
Pharmacologic class
Leukocyte Growth Factor

Active ingredients

Uses, dosage, side effects and warnings for Zarxio →

Package NDC codes (4)

Package NDCDescriptionSince
61314-318-011 BLISTER PACK in 1 CARTON (61314-318-01) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGEFeb 22, 2018
61314-318-102 BLISTER PACK in 1 CARTON (61314-318-10) / 5 SYRINGE in 1 BLISTER PACK (61314-318-05) / .5 mL in 1 SYRINGEFeb 22, 2018
61314-318-631 BLISTER PACK in 1 CARTON (61314-318-63) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGEJun 12, 2026
61314-318-692 BLISTER PACK in 1 CARTON (61314-318-69) / 5 SYRINGE in 1 BLISTER PACK (61314-318-65) / .5 mL in 1 SYRINGEJun 12, 2026

Other Zarxio products